Phase 3 Multicenter Randomized Double-Blind, Double-dummy, Active-Controlled Study Comparing Efficacy/Safety of Gastric-retentive, Controlled-release Accordion Pill Carbidopa/Levodopa to Immediate Release in Fluctuating Parkinson's Patients
Phase of Trial: Phase III
Latest Information Update: 20 Aug 2017
At a glance
- Drugs Levodopa/carbidopa (Primary) ; Levodopa/carbidopa
- Indications Parkinson's disease
- Focus Registrational; Therapeutic Use
- Acronyms Accordance
- Sponsors Intec Pharma
- 07 Aug 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Jun 2018.
- 28 Nov 2016 According to an Intec Pharma media release, the Michael J. Fox Foundation will further support patient recruitment, retention and enhance the conduct of this trial.
- 16 Nov 2016 Planned End Date changed from 1 Dec 2017 to 1 Jun 2018.